Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Obstructive Lung Diseases

  Free Subscription


Articles published in J Investig Allergol Clin Immunol

Retrieve available abstracts of 27 articles:
HTML format



Single Articles


    November 2021
  1. ANTONICELLI L, Tontini C, Garritani MS, Piga MA, et al
    Efficacy of mepolizumab in patients with concomitant severe eosinophilic asthma and severe chronic urticaria: an example of personalized medicine?
    J Investig Allergol Clin Immunol. 2021 Nov 29:0. doi: 10.18176/jiaci.0770.
    PubMed    


  2. VALERO A, Molina J, Nuevo J, Simon S, et al
    Economic consequences of the overuse of short-acting beta-adrenergic agonists (SABA) in the treatment of asthma in Spain.
    J Investig Allergol Clin Immunol. 2021 Nov 26:0. doi: 10.18176/jiaci.0767.
    PubMed     Abstract available


  3. KALM-STEPHENS P, Nordvall L, Janson C, Malinovschi A, et al
    Sex differences in baseline risk factors for the incidence of asthma between early adolescence and young adulthood.
    J Investig Allergol Clin Immunol. 2021 Nov 18:0. doi: 10.18176/jiaci.0763.
    PubMed     Abstract available


  4. IZQUIERDO JL, Almonacid C, Campos C, Morena D, et al
    Systemic Corticosteroids in Patients with Bronchial Asthma: A Real-Life Study.
    J Investig Allergol Clin Immunol. 2021 Nov 11:0. doi: 10.18176/jiaci.0765.
    PubMed     Abstract available


    October 2021
  5. VILLALOBOS-VIOLAN V, Betancor D, Mahillo-Fernandez I, Sastre J, et al
    Nonasthmatic Eosinophilic Bronchitis and Asthma Development: analysis of biomarkers.
    J Investig Allergol Clin Immunol. 2021 Oct 15:0. doi: 10.18176/jiaci.0738.
    PubMed    


    September 2021
  6. DAVILA I, Campo P, Cimbollek S, Almonacid Sanchez C, et al
    Cluster sub-analysis of patients with severe asthma who responded to omalizumab.
    J Investig Allergol Clin Immunol. 2021 Sep 28:0. doi: 10.18176/jiaci.0731.
    PubMed    


  7. GIL-MARTINEZ M, Rodrigo-Munoz JM, Sastre B, Canas JA, et al
    Serum microRNAs catalog asthmatic patients by phenotype.
    J Investig Allergol Clin Immunol. 2021 Sep 6:0. doi: 10.18176/jiaci.0753.
    PubMed     Abstract available


  8. DELGADO ROMERO J, Nunez Palomo S, Urendez Ruiz AM, Gomez Ruiz F, et al
    Referral criteria for asthma and the pandemic: new challenges, new responses.
    J Investig Allergol Clin Immunol. 2021 Sep 3:0. doi: 10.18176/jiaci.0747.
    PubMed    


    June 2021
  9. EXTREMERA ORTEGA AM, Moreno Lozano L, Gonzalez Jimenez OM, Borja Segade J, et al
    Findings in Chest High-Resolution Computed Tomography in Severe Asthma.
    J Investig Allergol Clin Immunol. 2021 Jun 29:0. doi: 10.18176/jiaci.0725.
    PubMed    


    April 2021
  10. BARRANCO P, Palao P, Ruiz I, Dominguez-Ortega J, et al
    Relationship Between IgE-Mediated Sensitization to Staphylococcus aureus Enterotoxin B, Asthma Severity, and Atopy.
    J Investig Allergol Clin Immunol. 2021;31:170-173.
    PubMed    


  11. DELGADO ROMERO J, Miralles Lopez JC, Alvarez Puebla M, Fernandez Ibanez E, et al
    Severe Asthma Units Accredited by the Spanish Society of Allergology and Clinical Immunology (SEAIC): Experience and Future.
    J Investig Allergol Clin Immunol. 2021;31:182-184.
    PubMed    


  12. DELGADO J, Martinez-Moragon E, Fernandez-Sanchez T
    Factors Affecting the Success of Step-up Therapy in Patients With Moderate-Severe Asthma: A Real-Life Study.
    J Investig Allergol Clin Immunol. 2021;31:145-150.
    PubMed     Abstract available


  13. TEJEDOR-ALONSO MA, Farias-Aquino E, Perez-Fernandez E, Moro-Moro M, et al
    Association Between Severity of Anaphylaxis and Co-occurrence of Respiratory Diseases: A Systematic Review and Meta-analysis of Observational Studies.
    J Investig Allergol Clin Immunol. 2021;31:132-144.
    PubMed     Abstract available


  14. DIAZ-CAMPOS RM, Garcia-Moguel I, Pina-Maiquez I, Fernandez-Rodriguez C, et al
    Prevalence and influence of COVID19 in asthma control and lung function in severe asthma patients under biological treatment.
    J Investig Allergol Clin Immunol. 2021 Apr 15:0. doi: 10.18176/jiaci.0695.
    PubMed    


  15. BUENDIA JA, Acuna-Cordero R, Rodriguez-Martinez CE
    Budget impact analysis of Fractional Exhaled Nitric Oxide Monitoring for the Management of Childhood Asthma: The Colombian National Health System perspective.
    J Investig Allergol Clin Immunol. 2021 Apr 13:0. doi: 10.18176/jiaci.0690.
    PubMed     Abstract available


    March 2021
  16. PLAZA V, Trigueros JA, Cisneros C, Dominguez-Ortega J, et al
    The Importance of Small Airway Dysfunction in Asthma. The GEMA-FORUM III Task Force.
    J Investig Allergol Clin Immunol. 2021 Mar 12:0. doi: 10.18176/jiaci.0686.
    PubMed    


    February 2021
  17. DELGADO J, Davila IJ, Dominguez-Ortega J
    Clinical Recommendations for the Management of Biological Treatments in Severe Asthma Patients: A Consensus Statement.
    J Investig Allergol Clin Immunol. 2021;31:36-43.
    PubMed     Abstract available


  18. MIRALLES LOPEZ JC, Escudero Pastor AI, Carbonell Martinez A, Navarro Garrido C, et al
    Benralizumab in Real Life.
    J Investig Allergol Clin Immunol. 2021;31:87-88.
    PubMed    


  19. PLAZA V, Giner J, Curto E, Alonso-Ortiz MB, et al
    Assessing Adherence by Combining the Test of Adherence to Inhalers With Pharmacy Refill Records.
    J Investig Allergol Clin Immunol. 2021;31:58-64.
    PubMed     Abstract available


    January 2021
  20. SATO H, Miyata Y, Inoue H, Tanaka A, et al
    Efficacy of Mepolizumab Extended Interval Dosing For Two Asthmatic Cases with Chronic Eosinophilic Pneumonia.
    J Investig Allergol Clin Immunol. 2021 Jan 26:0. doi: 10.18176/jiaci.0671.
    PubMed    


  21. BETANCOURT A, Zapatero A, Pola-Bibian B, Dominguez-Ortega J, et al
    Impact of Short-Term Exposure to Below Recommended PM10 Pollution Levels on Asthma Exacerbations.
    J Investig Allergol Clin Immunol. 2021 Jan 12:0. doi: 10.18176/jiaci.0663.
    PubMed    


    November 2020
  22. SERRANO P, Navas A, Ruiz-Leon B, Herrero L, et al
    Seasonal administration of omalizumab in patients with uncontrolled asthma and sensitization to olive pollen.
    J Investig Allergol Clin Immunol. 2020 Nov 25:0. doi: 10.18176/jiaci.0657.
    PubMed    


  23. KUROSAWA M, Shimizu Y, Sutoh Y, Sutoh E, et al
    Un-Sustained Response to Benralizumab in Eosinophilic Asthma with Previous 3 Year Mepolizumab Administration.
    J Investig Allergol Clin Immunol. 2020 Nov 2:0. doi: 10.18176/jiaci.0652.
    PubMed    


    October 2020
  24. CABALLERO ML, Dominguez J, Nin-Valencia AR, Sanchez-Ocando H, et al
    Eosinophil Count in Induced Sputum Could Be More Sensitive Than In Peripheral Blood to Phenotype Patients with Severe Eosinophilic Asthma.
    J Investig Allergol Clin Immunol. 2020 Oct 8:0. doi: 10.18176/jiaci.0647.
    PubMed    


    April 2020
  25. SHIMIZU Y, Kurosawa M, Sutoh Y, Sutoh E, et al
    Long-Term Treatment With Anti-Interleukin 5 Antibodies in a Patient with Chronic Eosinophilic Pneumonia.
    J Investig Allergol Clin Immunol. 2020;30:154-155.
    PubMed    


  26. OLAGUIBEL A, Oleaga M, Iraola A, Cortaberria R, et al
    Exhaled Nitric Oxide (eNO) Measurements With the New evernoa Device Are Valid and Reproducible Through an Extended Range of eNO Levels.
    J Investig Allergol Clin Immunol. 2020;30:147-149.
    PubMed    


    January 2020
  27. URIARTE SA, Sastre J
    Subcutaneous Immunotherapy With High-Dose Cat and Dog Extracts: A Real-life Study.
    J Investig Allergol Clin Immunol. 2020;30:169-174.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: